The neurobiology of SARS-CoV-2 infection
J Meinhardt, S Streit, C Dittmayer, RV Manitius… - Nature Reviews …, 2024 - nature.com
Worldwide, over 694 million people have been infected with SARS-CoV-2, with an estimated
55–60% of those infected develo** COVID-19. Since the beginning of the pandemic in …
55–60% of those infected develo** COVID-19. Since the beginning of the pandemic in …
Development of a definition of postacute sequelae of SARS-CoV-2 infection
T Thaweethai, SE Jolley, EW Karlson, EB Levitan… - Jama, 2023 - jamanetwork.com
Importance SARS-CoV-2 infection is associated with persistent, relapsing, or new symptoms
or other health effects occurring after acute infection, termedpostacute sequelae of SARS …
or other health effects occurring after acute infection, termedpostacute sequelae of SARS …
SARS-CoV-2 reinfections and long COVID in the post-omicron phase of the pandemic
We are reviewing the current state of knowledge on the virological and immunological
correlates of long COVID, focusing on recent evidence for the possible association between …
correlates of long COVID, focusing on recent evidence for the possible association between …
[HTML][HTML] The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia
Background Although vaccines have proved effective to prevent severe COVID-19, their
effect on preventing long-term symptoms is not yet fully understood. We aimed to evaluate …
effect on preventing long-term symptoms is not yet fully understood. We aimed to evaluate …
Key considerations during the transition from the acute phase of the COVID-19 pandemic: a narrative review
P Rzymski, M Pokorska-Śpiewak, T Jackowska… - Vaccines, 2023 - mdpi.com
The COVID-19 pandemic has been met with an unprecedented response from the scientific
community, leading to the development, investigation, and authorization of vaccines and …
community, leading to the development, investigation, and authorization of vaccines and …
B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2019
prompted scientific, medical, and biotech communities to investigate infection-and vaccine …
prompted scientific, medical, and biotech communities to investigate infection-and vaccine …
Vaccine effectiveness against long COVID in children
OBJECTIVES Vaccination reduces the risk of acute coronavirus disease 2019 (COVID-19) in
children, but it is less clear whether it protects against long COVID. We estimated vaccine …
children, but it is less clear whether it protects against long COVID. We estimated vaccine …
Translating insights into therapies for Long Covid
AAR Antar, AL Cox - Science translational medicine, 2024 - science.org
Long Covid is defined by a wide range of symptoms that persist after the acute phase of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Commonly …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Commonly …
[HTML][HTML] Long COVID facts and findings: a large-scale online survey in 74,075 Chinese participants
S Qin, Y Zhang, Y Li, L Huang, T Yang, J Si… - The Lancet Regional …, 2024 - thelancet.com
Background Research on long COVID in China is limited, particularly in terms of large-
sample epidemiological data and the effects of recent SARS-CoV-2 sub-variants. China …
sample epidemiological data and the effects of recent SARS-CoV-2 sub-variants. China …
Post–COVID-19 Condition After SARS-CoV-2 Infections During the Omicron Surge vs the Delta, Alpha, and Wild Type Periods in Stockholm, Sweden
P Hedberg, P Nauclér - The Journal of infectious diseases, 2024 - academic.oup.com
Little is known about the post–COVID-19 condition (PCC) after infections with different SARS-
CoV-2 variants. We investigated the risk of PCC diagnosis after primary omicron infections …
CoV-2 variants. We investigated the risk of PCC diagnosis after primary omicron infections …